Envision Scientific Abluminus Sirolimus Eluting Coronary Stent System - HSA Registration DE0502961
Access comprehensive regulatory information for Envision Scientific Abluminus Sirolimus Eluting Coronary Stent System in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0502961 and owned by Envision Scientific Private Limited. The device was registered on April 03, 2019.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Abluminus Sirolimus Eluting Coronary Stent System is indicated for improving luminal diameter in patients, including those with diabetes mellitus, acute myocardial infarction, symptomatic heart disease, stable angina, unstable angina or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with reference diameter 2.25mm to 5.00mm and lesions of length โค48 mm.

